Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,092 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis: Delphi consensus from the medical board of the National Psoriasis Foundation.
Chat VS, Ellebrecht CT, Kingston P, Gondo G, Bell S, Cordoro KM, Desai SR, Duffin KC, Feldman SR, Garg A, Gelfand JM, Gladman D, Green LJ, Gudjonsson J, Han G, Hawkes JE, Kircik L, Koo J, Langley R, Lebwohl M, Michael Lewitt G, Liao W, Martin G, Orbai AM, Reddy SM, Richardson V, Ritchlin CT, Schwartzman S, Siegel EL, Van Voorhees AS, Wallace EB, Weinberg JM, Winthrop KL, Yamauchi P, Armstrong AW. Chat VS, et al. Among authors: gladman d. J Am Acad Dermatol. 2024 Jun;90(6):1170-1181. doi: 10.1016/j.jaad.2023.12.070. Epub 2024 Feb 7. J Am Acad Dermatol. 2024. PMID: 38331098
Increased risk of severe generalized pustular psoriasis due to tuberculosis screening delay for spesolimab initiation.
Hackley M, Thampy D, Waseh S, Feldman SR, Blauvelt A, Weinberg JM, Schwartzman S, Liao W, Prussick R, Cohen JM, Hsu S; National Psoriasis Foundation Medical Board. Hackley M, et al. J Am Acad Dermatol. 2024 Feb;90(2):408-410. doi: 10.1016/j.jaad.2023.09.078. Epub 2023 Oct 10. J Am Acad Dermatol. 2024. PMID: 37821053 No abstract available.
Full Guidelines-From the Medical Board of the National Psoriasis Foundation: Perioperative management of systemic immunomodulatory agents in patients with psoriasis and psoriatic arthritis.
James WA, Rosenberg AL, Wu JJ, Hsu S, Armstrong A, Wallace EB, Lee LW, Merola J, Schwartzman S, Gladman D, Liu C, Koo J, Hawkes JE, Reddy S, Prussick R, Yamauchi P, Lewitt M, Soung J, Weinberg J, Lebwohl M, Glick B, Kircik L, Desai S, Feldman SR, Zaino ML. James WA, et al. Among authors: gladman d. J Am Acad Dermatol. 2024 Aug;91(2):251.e1-251.e11. doi: 10.1016/j.jaad.2024.03.008. Epub 2024 Mar 17. J Am Acad Dermatol. 2024. PMID: 38499181 Review.
Pathologic features of diabetic thick skin.
Hanna W, Friesen D, Bombardier C, Gladman D, Hanna A. Hanna W, et al. Among authors: gladman d. J Am Acad Dermatol. 1987 Mar;16(3 Pt 1):546-53. doi: 10.1016/s0190-9622(87)70072-3. J Am Acad Dermatol. 1987. PMID: 3819098
Efficacy and safety of tofacitinib in an open-label, long-term extension study in patients with psoriatic arthritis who received adalimumab or tofacitinib in a Phase 3 randomized controlled study: a post hoc analysis.
Gladman DD, Nash P, Mease PJ, FitzGerald O, Duench S, Cadatal MJ, Masri KR. Gladman DD, et al. Arthritis Res Ther. 2024 Dec 19;26(1):218. doi: 10.1186/s13075-024-03442-2. Arthritis Res Ther. 2024. PMID: 39702318 Free PMC article. Clinical Trial.
Interferon-α as a biomarker to predict renal outcomes in lupus nephritis.
Whittall Garcia LP, Gladman DD, Urowitz M, Bonilla D, Schneider R, Touma Z, Wither J. Whittall Garcia LP, et al. Among authors: gladman dd. Lupus Sci Med. 2024 Nov 28;11(2):e001347. doi: 10.1136/lupus-2024-001347. Lupus Sci Med. 2024. PMID: 39613334 Free PMC article.
1,092 results